Enveda Biosciences logo

Enveda Biosciences

Boulder, CO

Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologies systematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration. Enveda, launched in 2019, is based in San Francisco, California.

envedabio.com

Company Details

Founded

2019

Employees

Between 50 - 500 employees

Raised

$379,900,000

Headquarters Location

Boulder, CO

Public

No

Acquired

No

CEO

Viswa ColluruViswa Colluru

Founders

Pieter Dorrestein
Pieter Dorrestein
Viswa Colluru
Viswa Colluru

Company Collections

These are collections Enveda Biosciences is a part of. Click on the collection name to view similar companies.

Enveda Biosciences' Industries

Enveda Biosciences' Tech Stack

Enveda Biosciences' Investors

Enveda Biosciences Headquarters Location

Boulder, CO 80310

Total Amount Raised: $379,900,000

Enveda Biosciences' Investors

Enveda Biosciences Funding Rounds

  • Series C

    $20,000,000

    Series C Investors

    Sanofi
  • Series C

    $130,000,000

    Series C Investors

    FPV Ventures
    Kinnevik
    The Nature Conservancy
    True Ventures
    Lux Capital
    Dimension Capital Management
    Lingotto
    Henry Kravis
    Premji Invest
    Baillie Gifford
    Cresset
  • Series B

    $55,000,000

    Series B Investors

    Lingotto
    True Ventures
    Microsoft
    FPV Ventures
    Albert Azout
    Premji Invest
    Jazz Venture Partners
    The Nature Conservancy
    Kinnevik
  • Series B

    $51,000,000

    Series B Investors

    Kinnevik
    True Ventures
    Wireframe Ventures
    FPV Ventures
    Dimension
    Henry Kravis
  • Series B

    $55,000,000

    Series B Investors

    Dimension
    FPV Ventures
    Jazz Venture Partners
    Amino Collective
    True Ventures
    Allen & Company
    Albert Azout
    Lux Capital
    Possible Ventures
    Hummingbird Ventures
    Wireframe Ventures
    Two Sigma Ventures
  • Debt Financing

    $13,000,000

    Debt Financing Investors

    First Citizens Bank
  • Series A

    $51,000,000

    Series A Investors

    Lux Capital
    Catalio Capital Management
    Wireframe Ventures
    True Ventures
    Hummingbird Ventures
    Chris Gibson
    Lifeforce Capital
    Two Sigma Ventures
    Village Global
    Matt De Silva
    Bioverge
  • Seed

    $4,900,000

    Seed Investors

    True Ventures
    Village Global
    Chris Gibson
    Wireframe Ventures
    Vertical Partners
Funding info provided by Diffbot.

Enveda Biosciences Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Enveda Biosciences.

Recent reviews